BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15589853)

  • 21. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation.
    Filicori M; Cognigni GE; Gamberini E; Parmegiani L; Troilo E; Roset B
    Fertil Steril; 2005 Aug; 84(2):394-401. PubMed ID: 16084880
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of concentration of circulating luteinizing hormone in late-follicle phase on the outcome of in vitro fertilization for normogonadotrophic women].
    Sun H; Hu Y; Wang B; Chen Q; Zhang N; Chen H; Wang J; Xu Z
    Zhonghua Nan Ke Xue; 2004 Dec; 10(12):912-5. PubMed ID: 15638021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
    Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
    Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ovarian response and pregnancy outcome related to midfollicular LH levels in down-regulated women undergoing assisted reproduction.
    Ferrari B; Barusi L; Lanna M; Coppola F
    J Reprod Med; 2004 Mar; 49(3):148-52. PubMed ID: 15098883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer.
    Ku SY; Choi YS; Jee BC; Suh CS; Choi YM; Kim JG; Moon SY; Kim SH
    Gynecol Endocrinol; 2005 Oct; 21(4):227-31. PubMed ID: 16316845
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of recombinant LH (rLH) supplementation during controlled ovarian hyperstimulation (COH) in normogonadotrophic women with an initial inadequate response to recombinant FSH (rFSH) after pituitary downregulation.
    De Placido G; Alviggi C; Mollo A; Strina I; Ranieri A; Alviggi E; Wilding M; Varricchio MT; Borrelli AL; Conforti S
    Clin Endocrinol (Oxf); 2004 May; 60(5):637-43. PubMed ID: 15104569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A relative reduction in mid-follicular LH concentrations during GnRH agonist IVF/ICSI cycles leads to lower live birth rates.
    Lahoud R; Al-Jefout M; Tyler J; Ryan J; Driscoll G
    Hum Reprod; 2006 Oct; 21(10):2645-9. PubMed ID: 16785261
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does exogenous LH in ovarian stimulation improve assisted reproduction success? An appraisal of the literature.
    Hill MJ; Levy G; Levens ED
    Reprod Biomed Online; 2012 Mar; 24(3):261-71. PubMed ID: 22285265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diminished intrafollicular estradiol levels in in vitro fertilization cycles from women with reduced ovarian response to recombinant human follicle-stimulating hormone.
    Foong SC; Abbott DH; Lesnick TG; Session DR; Walker DL; Dumesic DA
    Fertil Steril; 2005 May; 83(5):1377-83. PubMed ID: 15866572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of urinary versus recombinant follicle-stimulating hormone on platelet function and other hemostatic variables in controlled ovarian hyperstimulation.
    Bar J; Orvieto R; Lahav J; Hod M; Kaplan B; Fisch B
    Fertil Steril; 2004 Dec; 82(6):1564-9. PubMed ID: 15589861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating the role of exogenous luteinizing hormone in poor responders undergoing in vitro fertilization with gonadotropin-releasing hormone antagonists.
    Chung K; Krey L; Katz J; Noyes N
    Fertil Steril; 2005 Aug; 84(2):313-8. PubMed ID: 16084870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of mixed protocols with Bravelle (human-derived FSH) and Repronex (hMG) to assess clinical efficacy (EMBRACE) in women undergoing in vitro fertilization.
    Keye WR; Marrs RP; Check JH; Schnell V; Surrey M; Marshall DC;
    Fertil Steril; 2004 Aug; 82(2):348-57. PubMed ID: 15302283
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Letrozole co-treatment in infertile women 40 years old and older receiving controlled ovarian stimulation and intrauterine insemination.
    Bedaiwy MA; Shokry M; Mousa N; Claessens A; Esfandiari N; Gotleib L; Casper R
    Fertil Steril; 2009 Jun; 91(6):2501-7. PubMed ID: 18501899
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A randomized clinical trial of clomiphene citrate versus low dose recombinant FSH for ovarian hyperstimulation in intrauterine insemination cycles for unexplained and male subfertility.
    Dankert T; Kremer JA; Cohlen BJ; Hamilton CJ; Pasker-de Jong PC; Straatman H; van Dop PA
    Hum Reprod; 2007 Mar; 22(3):792-7. PubMed ID: 17110396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FSH and LH together in ovarian stimulation.
    Levi-Setti PE; Cavagna M; Baggiani A; Zannoni E; Colombo GV; Liprandi V
    Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115 Suppl 1():S34-9. PubMed ID: 15196714
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of recombinant human LH (lutropin alfa) in the late stimulation phase of assisted reproduction cycles: a double-blind, randomized, prospective study.
    Tarlatzis B; Tavmergen E; Szamatowicz M; Barash A; Amit A; Levitas E; Shoham Z
    Hum Reprod; 2006 Jan; 21(1):90-4. PubMed ID: 16172149
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of rescue in vitro fertilization converted from high-response gonadotropin intrauterine insemination cycles in terms of implantation and pregnancy rates as compared with matched controls.
    Haydardedeoglu B; Bagis T; Simsek E; Cok T; Hacivelioglu SO; Erkanli S
    Fertil Steril; 2009 Jul; 92(1):137-42. PubMed ID: 18692785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IVF/ICSI outcome and serum LH concentration on day 1 of ovarian stimulation with recombinant FSH under pituitary suppression.
    Bjercke S; Fedorcsak P; Abyholm T; Storeng R; Ertzeid G; Oldereid N; Omland A; Tanbo T
    Hum Reprod; 2005 Sep; 20(9):2441-7. PubMed ID: 15919773
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial.
    Barroso G; Menocal G; Felix H; Rojas-Ruiz JC; Arslan M; Oehninger S
    Fertil Steril; 2006 Nov; 86(5):1428-31. PubMed ID: 16978619
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of two doses of recombinant luteinizing hormone supplementation in an unselected group of women undergoing follicular stimulation for in vitro fertilization.
    Lisi F; Rinaldi L; Fishel S; Caserta D; Lisi R; Campbell A
    Fertil Steril; 2005 Feb; 83(2):309-15. PubMed ID: 15705367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.